KRO-14037

mk-7246

1218918-62-7
98% min.
scale-up (10-1,000 kg)


KRO-10191

Selexipag (JAN/USAN/INN); UNII-5EXC0E384L; NS-304; 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide; Selexipag [USAN:INN]; Selexipag

475086-01-2
98% min.
scale-up (10-1,000 kg)
C26H32N4O4S

KRO-00475

Eklira; LAS W-330; Aclidinium Bromide; Tudorza Pressair; [(3R)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate,bromide; Bretaris; UNII-UQW7UF9N91; (3R)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-1-(3-phenoxypropyl)quinuclidin-1-ium bromide

320345-99-1
98% min.
scale-up (10-1,000 kg)
C26H30BrNO4S2

KRO-02149

vilanterol

503070-58-4
98% min.
scale-up (10-1,000 kg)
C24H33Cl2NO5.C20H16O2

KRO-11638

2-(2-(2-methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide; N-methyl-2-{[2-{[2-(methyloxy)-4-(4-morpholinyl)phenyl]amino}-5-(trifluoromethyl)-4-pyridinyl]amino}benzamide; 3,6,9-trioxaundecyl (4-methylbenzene)sulfonate; triethylene glycol monoethyl ether p-tosylate; triethylene glycol monoethyl ether p-toluenesulfonate; 2-(2-(2-ethoxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate; triethyleneglycol monoethyl ether tosylate; Ethanol,2-[2-(2-ethoxyethoxy)ethoxy]-,4-methylbenzenesulfonate; 2-{[2-{[2-Methoxy-4-(4-morpholinyl)phenyl]amino}-5-(trifluorometh yl)-4-pyridinyl]amino}-N-methylbenzamide hydrochloride (1:1); 2-[[2-[[2-Methoxy-4-(4-morpholinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyridinyl]amino]-N-methylbenzamide; SR 2516

1061353-68-1
98% min.
scale-up (10-1,000 kg)
C25H26F3N5O3

KRO-14759

(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one; GNE 390; (2s)-1-(4-{[2-(2-Aminopyrimidin-5-Yl)-7-Methyl-4-(Morpholin-4-Yl)thieno[3,2-D]pyrimidin-6-Yl]methyl}piperazin-1-Yl)-2-Hydroxypropan-1-One; Apitolisib; [14C]-GDC-0980; GDC 0980

1032754-93-0
98% min.
scale-up (10-1,000 kg)
C23H30N8O3S

KRO-09822

N-tert-butyl-3-{[5-methyl-2-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}amino)pyrimidin-4-yl]amino}benzenesulfonamide; 2TA; N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide; Fedratinib; Fedratinib

936091-26-8
98% min.
scale-up (10-1,000 kg)
C27H36N6O3S

KRO-15857

N-(Cyanomethyl)-4-(2-((4-morpholinophenyl)-amino)pyrimidin-4-yl)benzamide

1056634-68-4
98% min.
scale-up (10-1,000 kg)
C23H22N6O2

KRO-16768

Alisertib; MLN-8237,MLN8237; MLN 8237

1028486-01-2
98% min.
scale-up (10-1,000 kg)
C27H20ClFN4O4

KRO-15800

Dacomitinib [USAN]; (2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide; (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide; Dacomitinib (USAN/INN); Dacomitinib

1110813-31-4
98% min.
scale-up (10-1,000 kg)
C24H25ClFN5O2

KRO-11767

(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid; PDGFR TYROSINE KINASE INHIBITOR VI, SU6668

210644-62-5
98% min.
scale-up (10-1,000 kg)
C18H18N2O3

KRO-09800

Tivantinib/ARQ197/ARQ-197; Tivantinib (ARQ 197); (-)-3(R),4(R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione; (-)-3(R),4(R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione,(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione; (3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidinedione; Tivantinib; Tivantinib; (-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione

905854-02-6
98% min.
scale-up (10-1,000 kg)
C23H19N3O2

KRO-15907

4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-7-methoxy-3-phenyl-2H-chromen-2-one; 2H-1-Benzopyran-2-one,7-methoxy-3-phenyl-4-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl); 4-(4-(4-(3-acrylamidophenylamino)-5-fluoropyrimidin-2-ylamino)phenoxy)-N-methylpicolinamide; Coumarin,7-methoxy-3-phenyl-4-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl); 7-Methoxy-3-phenyl-4-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)coumarin

1202759-32-7
98% min.
scale-up (10-1,000 kg)
C26H22FN7O3

KRO-16681

N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide; AVL-292

1202757-89-8
98% min.
scale-up (10-1,000 kg)
C22H22FN5O3

KRO-15781

Vilanterol; vilanterolum

929916-05-2
98% min.
scale-up (10-1,000 kg)
C21H24ClNO4

KRO-31375

3-floroacetanilide


98% min.
scale-up (10-1,000 kg)


KRO-34475

O-DIPHENYL PHENYL ETHER; 2-PHENYLOXYBIPHENYL; 1,1''-Biphenyl,2-phenoxy; Phenoxy-2-diphenyl; 2-BIPHENYL PHENYL ETHER; 2-Phenoxydiphenyl; phenoxybiphenyl; 2-BIPHENYLYLPHENYL ETHER; o-biphenylyl phenyl ether; 2-Phenoxy-1,1''-biphenyl; 2-Phenyldiphenylether

6738-04-1
98% min.
scale-up (10-1,000 kg)
C18H14O

KRO-33594

Biphenyl,3,4-dichloro; 3,4-Dichlor-biphenyl; 3,4-dichloro-1,1''-biphenyl; 3,4-PCB; 1,1''-Biphenyl,3,4-dichloro; 4-phenyl-1,2-dichlorobenzene; 3,1''-biphenyl; 3,4-DICHLOROBIPHENYL; 3,4-dichlorodiphenyl; PCB No 12

2974-92-7
98% min.
scale-up (10-1,000 kg)
C12H8Cl2

KRO-16967

2-BROMO-9,9-DIHEXYL-9H-FLUORENE; 2-Bromo-9,9-di-n-hexylfluoren

226070-05-9
98% min.
scale-up (10-1,000 kg)
C25H33Br

KRO-23844

.4-bromo-spirobifluorene; 4-bromo-9,9''-Spirobi[9H-fluorene; 4-bromo-9,9''-spirobifluorene; 4-broMo-9,9''-spirobifluorene; 4-Dromo-9,9''-spirobifluorene; 4-Dibromo-9,9''-spirobifluorene

1161009-88-6
98% min.
scale-up (10-1,000 kg)
C25H15Br